Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ursolic acid nano-liposomes for injection in advanced hepatocellular carcinoma
CTR20230593Phase 2Terminated
- Sponsor
- Lyric Robot
- Start
- May 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ursolic acid in hepatocellular carcinoma (HCC), sponsored by Lyric Robot. Started May 2023; status: terminated.
02
Drugs
ursolic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20230593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230593.